The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Soluble BTN2A1 as a potential predictive biomarker of immune checkpoint inhibitor efficacy in advanced non-small cell lung cancer (NSCLC).
 
Philippe Rochigneux
Honoraria - AstraZeneca
 
Anne Sophie Chretien
No Relationships to Disclose
 
Delphine Rossille
No Relationships to Disclose
 
Brice Chanez
No Relationships to Disclose
 
Emilien Billon
No Relationships to Disclose
 
Stephane Fattori
No Relationships to Disclose
 
Romain Corre
No Relationships to Disclose
 
Jihane Pakradouni
No Relationships to Disclose
 
Anthony Goncalves
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Cascadian Therapeutics (Inst); Lilly (Inst); Merus (Inst); MSD (Inst); Nektar (Inst); Novartis (Inst); Roche (Inst); Roche/Genentech (Inst); Sanofi/Aventis (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Novartis; Pfizer; Roche/Genentech
 
Thierry Fest
No Relationships to Disclose
 
Anne Madroszyk
No Relationships to Disclose
 
Daniel Olive
Leadership - ImageIQ
Stock and Other Ownership Interests - ImageIQ